Your browser doesn't support javascript.
loading
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.
Conroy, T; Hebbar, M; Bennouna, J; Ducreux, M; Ychou, M; Llédo, G; Adenis, A; Faroux, R; Rebischung, C; Kockler, L; Douillard, J Y.
  • Conroy T; Centre Alexis Vautrin and Nancy University, EA 4360, Vandoeuvre-lès-Nancy 54511, France. t.conroy@nancy.fnclcc.fr
Br J Cancer ; 102(1): 59-67, 2010 Jan 05.
Article en En | MEDLINE | ID: mdl-19920832

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2010 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Qualitative_research / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2010 Tipo del documento: Article